DOI:
10.1055/s-00000101
Zeitschrift für Phytotherapie
LinksClose Window
References
Gordon M, Guralnik M, Kaneko Y et al.
A phase II controlled study of a combination of the immune modulator, lentinan, with didanosine (DDI) in HIV patients with CD4 cells of 200-500/MM(3).
J Med 1995;
26: 193-207
We do not assume any responsibility for the contents of the web pages of other providers.